Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Activin RIB/ALK-4 Antibody, R&D Systems™

Goat Polyclonal Antibody
$200.50 - $549.50
Specifications
Antigen | Activin RIB/ALK-4 |
---|---|
Concentration | LYOPH |
Dilution | Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL, Blockade of Receptor-ligand Interaction |
Applications | Western Blot, Immunohistochemistry, Blockade of Receptor-ligand Interaction |
Classification | Polyclonal |
Description
Activin RIB/ALK-4 Polyclonal specifically detects Activin RIB/ALK-4 in Mouse samples. It is validated for Western Blot, Immunohistochemistry, Blockade of Receptor-ligand Interaction.Specifications
Activin RIB/ALK-4 | |
Western Blot 0.1 ug/mL, Immunohistochemistry 5-15 ug/mL, Blockade of Receptor-ligand Interaction | |
Polyclonal | |
Goat | |
Mouse | |
activin A receptor, type IB, Activin receptor type IB, Activin receptor-like kinase 4, ActivinRIB, ActRIB, ACVR1B, ACVRLK4ACTR-IB, ALK4, ALK-4, ALK4activin A receptor, type II-like kinase 4, EC 2.7.11, EC 2.7.11.30, Serine/threonine-protein kinase receptor R2, SKR2activin receptor type-1B | |
ACVR1B | |
IgG | |
Affinity Purified | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
LYOPH | |
Western Blot, Immunohistochemistry, Blockade of Receptor-ligand Interaction | |
Unconjugated | |
RUO | |
Q61271 | |
91 | |
Mouse myeloma cell line NS0-derived recombinant mouse Activin RIB/ALK-4 Leu32-Glu126 Accession # Q61271 | |
Primary | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Detects mouse Activin RIB/ALK-4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 50% cross-reactivity with recombinant human (rh) Activin RIB is observed, 5% cross-reactivity with rhActivin R1A is observed and less than 1% cross-reactivity with rhActivin RIIA and rhActivin RIIB is observed. |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title